GMO Beyond China ETF
BCHI
5 hedge funds and large institutions have $1.91M invested in GMO Beyond China ETF in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
62% more capital invested
Capital invested by funds: $1.18M → $1.91M (+$735K)
5.36% more ownership
Funds ownership: 10.31% → 15.67% (+5.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$626K |
| 2 |
HC
Hara Capital
Bellevue,
Washington
|
+$12.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.54K |
Top Sellers
BCHI Hedge Fund Activity: Q4 2025 in Review
5 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q4 2025, worth a combined $1.91M — up 62% from $1.18M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BCHI positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $626K.
- 5 institutional investors held GMO Beyond China ETF (BCHI) as of Q4 2025, up from 3 in Q3 2025.
- Funds reported $1.91M of GMO Beyond China ETF stock for Q4 2025, up 62% quarter-over-quarter.
- 2 funds opened new GMO Beyond China ETF positions in Q4 2025 and 0 closed out, a net change of +2 holders.
- The largest GMO Beyond China ETF buyer in Q4 2025 was Citadel Advisors, an estimated $626K added.
Based on aggregated 13F filings for Q4 2025.